Cargando…

1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents

We describe herein the synthesis and antileishmanial activity of 1,3‐bis(aryloxy)propan‐2‐ols. Five compounds (2, 3, 13, 17, and 18) exhibited an effective antileishmanial activity against stationary promastigote forms of Leishmania amazonensis (IC (50) < 15.0 μm), and an influence of compound li...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavorato, Stefânia N., Duarte, Mariana C., Lage, Daniela P., Tavares, Carlos A. P., Coelho, Eduardo A. F., Alves, Ricardo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697679/
https://www.ncbi.nlm.nih.gov/pubmed/28590516
http://dx.doi.org/10.1111/cbdd.13024
_version_ 1783280664863309824
author Lavorato, Stefânia N.
Duarte, Mariana C.
Lage, Daniela P.
Tavares, Carlos A. P.
Coelho, Eduardo A. F.
Alves, Ricardo J.
author_facet Lavorato, Stefânia N.
Duarte, Mariana C.
Lage, Daniela P.
Tavares, Carlos A. P.
Coelho, Eduardo A. F.
Alves, Ricardo J.
author_sort Lavorato, Stefânia N.
collection PubMed
description We describe herein the synthesis and antileishmanial activity of 1,3‐bis(aryloxy)propan‐2‐ols. Five compounds (2, 3, 13, 17, and 18) exhibited an effective antileishmanial activity against stationary promastigote forms of Leishmania amazonensis (IC (50) < 15.0 μm), and an influence of compound lipophilicity on activity was suggested. Most of the compounds were poorly selective, as they showed toxicity toward murine macrophages, except 17 and 18, which presented good selective indexes (SI ≥ 10.0). The five more active compounds (2, 3, 13, 17, and 18) were selected for the treatment of infected macrophages, and all of them were able to reduce the number of internalized parasites by more than 80%, as well as the number of infected macrophages by more than 70% in at least one of the tested concentrations. Altogether, these results demonstrate the potential of these compounds as new hits of antileishmanial agents and open future possibilities for them to be tested in in vivo studies.
format Online
Article
Text
id pubmed-5697679
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56976792017-11-28 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents Lavorato, Stefânia N. Duarte, Mariana C. Lage, Daniela P. Tavares, Carlos A. P. Coelho, Eduardo A. F. Alves, Ricardo J. Chem Biol Drug Des Research Articles We describe herein the synthesis and antileishmanial activity of 1,3‐bis(aryloxy)propan‐2‐ols. Five compounds (2, 3, 13, 17, and 18) exhibited an effective antileishmanial activity against stationary promastigote forms of Leishmania amazonensis (IC (50) < 15.0 μm), and an influence of compound lipophilicity on activity was suggested. Most of the compounds were poorly selective, as they showed toxicity toward murine macrophages, except 17 and 18, which presented good selective indexes (SI ≥ 10.0). The five more active compounds (2, 3, 13, 17, and 18) were selected for the treatment of infected macrophages, and all of them were able to reduce the number of internalized parasites by more than 80%, as well as the number of infected macrophages by more than 70% in at least one of the tested concentrations. Altogether, these results demonstrate the potential of these compounds as new hits of antileishmanial agents and open future possibilities for them to be tested in in vivo studies. John Wiley and Sons Inc. 2017-06-28 2017-11 /pmc/articles/PMC5697679/ /pubmed/28590516 http://dx.doi.org/10.1111/cbdd.13024 Text en © 2017 The Authors. Chemical Biology & Drug Design Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Lavorato, Stefânia N.
Duarte, Mariana C.
Lage, Daniela P.
Tavares, Carlos A. P.
Coelho, Eduardo A. F.
Alves, Ricardo J.
1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
title 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
title_full 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
title_fullStr 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
title_full_unstemmed 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
title_short 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
title_sort 1,3‐bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697679/
https://www.ncbi.nlm.nih.gov/pubmed/28590516
http://dx.doi.org/10.1111/cbdd.13024
work_keys_str_mv AT lavoratostefanian 13bisaryloxypropan2olsaspotentialantileishmanialagents
AT duartemarianac 13bisaryloxypropan2olsaspotentialantileishmanialagents
AT lagedanielap 13bisaryloxypropan2olsaspotentialantileishmanialagents
AT tavarescarlosap 13bisaryloxypropan2olsaspotentialantileishmanialagents
AT coelhoeduardoaf 13bisaryloxypropan2olsaspotentialantileishmanialagents
AT alvesricardoj 13bisaryloxypropan2olsaspotentialantileishmanialagents